Healthcare Industry News: HSMN NewsFeed
News Release - December 20, 2017
PENTAX Medical Announces Launch Of First FDA-Cleared HD Duodenoscope With Disposable Distal CapC.A.P. HD Duodenoscope Offers Innovative Cleaning and Reprocessing Capabilities as well as Enhanced Visualization
MONTVALE, N.J., Dec. 20, 2017 -- (Healthcare Sales & Marketing Network) -- PENTAX Medical, an industry leader in endoscopic imaging, announced the U.S. launch of its new C.A.P. HD Duodenoscope (ED34-i10T), the first FDA-cleared duodenoscope with a disposable distal cap.
Duodenoscopes are used during endoscopic retrograde cholangiopancreatography (ERCP), which is a procedure that uses a combination of video endoscopy and fluoroscopic imaging to diagnose and treat conditions associated with the pancreaticobiliary system.
The C.A.P. HD Duodenoscope is designed to improve the standards of treatment and safety for both routine and advanced ERCP via improved Clarity, Access, and Performance. It features HD+ High Definition imaging, improved clinical control, as well as a detachable and disposable Distal Cap to improve access for cleaning and reprocessing.
"We believe the new disposable distal cap represents a major step towards lowering the risk of future infections associated with these devices," said William Maisel, M.D., M.P.H., acting director of the Office of Device Evaluation in the FDA's Center for Devices and Radiological Health, in a recent FDA News Release.i
"PENTAX Medical is pleased to bring this new innovation to the market as part of our multi-tiered Medical Device Hygiene and Infection Control Strategy, specifically designed to improve the delivery of clinical care and overall infection control efforts by reprocessing technicians and nursing professionals," said Dr. Hudson Garrett, Global Chief Clinical Officer for PENTAX Medical.
As the latest addition to the i10 Series of endoscopes, the new C.A.P. HD Duodenoscope continues the organization's dedication to advanced imaging excellence with HD+ visualization, PENTAX i-SCAN™ and OE Optical Enhancement technology. These advances are designed to help endoscopists visualize the mucosa in detail, identify abnormal tissue, and locate the papilla for cannulation. Additionally, it offers the lightweight i10 Series Ergonomic Control Body for improved comfort and handling, as well as a redesigned elevator mechanism to enhance stability.
"In my practice, the use of the ED34-i10T [C.A.P. HD Duodenoscope] has helped improve the quality of procedures as its high definition image provides increased detailed visualization of the papilla by using advanced digital imaging technologies. This allows us to differentiate between normal papillae and adenomas," said Dr. Carlos Robles-Medranda, Guayaquil, Instituto Ecuatoriano de Enfermedades Digestivas (IECED), University Hospital OMNI, Ecuador. "Additionally, the new design provides greater comfort during long procedures and requires less lever force to cannulate and maintain the required positioning, making this scope a must have tool for successful ERCP procedures."
"PENTAX Medical is committed to advancing endoscopy with innovations that help improve clinical and economic outcomes and enhance patient and provider satisfaction," said David Woods, President, PENTAX Medical, Americas. "With the C.A.P. HD Duodenoscope, we responded to a clinical need in a meaningful way."
To learn more about this product, please call 1-800-431-5880 or visit us at http://www.pentaxmedical.com/us/.
About PENTAX Medical
PENTAX Medical is a division of Hoya Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopy, informatics, speech, voice, and swallowing assessment products as well as services, with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe. PENTAX Medical employees represent the diverse countries where we do business, allowing us to provide innovative solutions tailored to meet local needs.
i www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm576753.htm Accessed on 07-Dec-2017.
Source: PENTAX Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsAvantis Medical Names Matt Frushell as President and CEO, Salmaan Hameed as CTO, as Company Moves to Full Commercial Operation
PENTAX Medical Introduces Next-Generation C2 CryoBalloon(TM) Ablation System for Treatment of Barrett's Esophagus
PENTAX Medical Announces U.S. Deal To Distribute Third Eye(R) Panoramic(TM) Imaging System For Colon Cancer Screening